molecules-logo

Journal Browser

Journal Browser

Natural Products and Microbiology in Human Health, 2nd Edition

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 319

Special Issue Editor


E-Mail Website
Guest Editor
Environmental Futures Research Institute, Griffith University, Brisbane, Australia
Interests: biochemistry and cell biology; microbiology; cancer; inflammation; drug discovery; natural products; ethnobotany
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Human health is closely linked to microbial exposure, and to the maintenance of the microbiome. Pathogenic bacteria, fungi, protozoa, and viruses cause a myriad of diseases that may seriously impact human health. The use of chemotherapies to combat these diseases has long relied upon traditional medicines and natural products. Indeed, penicillin (and the majority of other first-generation antibiotics) were initially identified as bacterial and fungal natural products, used by microbes to provide a competitive advantage over other cells in their environment. A large portion of the antibiotics produced as second- and third-generation antibiotics were based on the chemical scaffolds of the first-generation natural product antibiotics. Notably, even before the development of current antibiotic therapies, natural medicines containing bioactive natural products were used to combat pathogenic diseases. Plant-based medicines were particularly important in this respect and continue to be important in many regions of the world. With the recent development of multiple antibiotic-resistant pathogens, the discovery of novel antibiotic therapies is a priority for medical science and natural products are promising as new drug leads.

Natural products and the microbiome may also impact human health in other fundamental ways. The human microbiome comprises a myriad of bacteria and archaea, protozoa, fungi, and viruses, both within and outside our bodies. Alterations in the natural microbial balance may affect human health via disease induction. Microbiome dysbiosis increases the host’s susceptibility to disease by allowing pathogenic microbes to flourish and out-compete the beneficial microflora. Natural products may also function as pre- or probiotics, allowing the natural microflora and beneficial microbes to dominate, thereby inhibiting the growth of pathogens. Therefore, natural products can also influence human health by modulating the human microbiome.  

We invite the submission of original research and review articles focusing on natural products and microbiology and their effects on human health. Potential topics include, but are not limited to, the following:

  • The antimicrobial activity of natural products.
  • Identification of natural products with antimicrobial activity.
  • Plant-derived natural products and their effects on microbes important to human health.
  • Microbial-derived natural products and their effects on microbes important to human health.
  • Natural products derived from marine organisms and their effects on microbes important to human health.
  • Antibacterial activity of natural products against antibiotic-resistant bacteria.
  • Potentiation of antibiotic (or probiotic) activity by natural products.
  • Modulation of the human microbiome and disease induction by natural products and traditional medicines.
  • Microbiome dysbiosis (or microbiome maintenance) induced by natural products, and its effects on human health.
  • Natural products as nutritional factors and antioxidants in maintaining gastrointestinal microbial homeostasis and human health.
  • Natural products such as probiotics (and/or prebiotics) and their affects on human health.

Dr. Ian Edwin Cock
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • traditional medicine
  • antibiotics
  • antibiotic natural products
  • probiotics
  • novel antimicrobial therapies
  • microbial toxins
  • phytochemicals
  • antibiotic-resistant bacteria
  • drug potentiation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

40 pages, 7342 KB  
Review
Traditional Uses, Phytochemicals, Biological Activities, and Biotechnological Applications of Serjania Species: A Review of Current Knowledge and Future Prospects
by Ana Belem Rubio-García, Cecilia Guadalupe de Loza-García, Jorge Manuel Silva-Jara, Napoleón González-Silva, Luis Antonio Ramirez-Contreras, Zuamí Villagran, Omar Graciano-Machuca, Jessica del Pilar Ramírez-Anaya, Fernando Martínez-Esquivias and Luis Miguel Anaya-Esparza
Molecules 2026, 31(9), 1477; https://doi.org/10.3390/molecules31091477 - 29 Apr 2026
Abstract
The genus Serjania (family Sapindaceae) comprises more than 240 species, primarily distributed in Brazil and Mexico, and it exhibits considerable ethnobotanical and therapeutic potential. Ethnobotanical evidence documents the widespread use of decoctions prepared from the leaves, stems, and roots of Serjania species for [...] Read more.
The genus Serjania (family Sapindaceae) comprises more than 240 species, primarily distributed in Brazil and Mexico, and it exhibits considerable ethnobotanical and therapeutic potential. Ethnobotanical evidence documents the widespread use of decoctions prepared from the leaves, stems, and roots of Serjania species for the treatment of gastrointestinal disorders, renal pain, inflammatory conditions, and infections. Among the most extensively studied species are S. marginata, S. erecta, S. lethalis, S. caracasana, S. goniocarpa, S. schiedeana, S. yucatenensis, S. triquetra, and S. racemose. Phytochemical research has identified a diverse array of bioactive secondary metabolites, including saponins, flavonoids, phenolic acids, tannins, and terpenoids. Significant experimental evidence supports the broad spectrum of biological activities of these Serjania species, including antimicrobial, anti-inflammatory, antioxidant, gastroprotective, antihypertensive, analgesic, antivenom, cytotoxic, antimutagenic, anti-ulcer, photoprotective, antiparasitic, and vasorelaxant effects, as demonstrated in both in vitro and in vivo models. Although preliminary toxicity assessments of extracts from some Serjania species in murine models, Oreochromis niloticus (Nile tilapia), and Artemia salina suggest a favorable safety profile, significant research gaps remain. Additionally, several Serjania species have shown potential as natural pesticides and bioherbicides, highlighting their relevance in agricultural applications. Future studies should prioritize the isolation and structural characterization of individual bioactive compounds, as well as the elucidation of their molecular mechanisms of action, moving beyond crude extract-based screening approaches. Overall, this review summarizes current knowledge on traditional uses, phytochemical composition, biological activities, and biotechnological applications of Serjania species. Full article
(This article belongs to the Special Issue Natural Products and Microbiology in Human Health, 2nd Edition)
Show Figures

Graphical abstract

Back to TopTop